Development of high-specific-activity 68Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors

Melchor V. Cantorias, Said D. Figueroa, Thomas P. Quinn, John R. Lever, Timothy J. Hoffman, Lisa D. Watkinson, Terry L. Carmack, Cathy S. Cutler

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Development of high-specific-activity <sup>68</sup>Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences